BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37248785)

  • 1. Increased risk of pancreatic, thyroid, prostate and breast cancers in men with a family history of breast cancer: A population-based study.
    Song H; Jung YS; Tran TXM; Moon CM; Park B
    Int J Cancer; 2023 Sep; 153(5):950-957. PubMed ID: 37248785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Breast Cancer Family History With Breast Density Over Time in Korean Women.
    Tran TXM; Chang Y; Kim S; Song H; Ryu S; Park B
    JAMA Netw Open; 2023 Mar; 6(3):e232420. PubMed ID: 36897591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer.
    Sim EJ; Ko KP; Ahn C; Park SM; Surh YJ; An S; Kim SW; Lee MH; Lee JW; Lee JE; Kim KS; Yom CK; Kim HA; Park SK
    Breast Cancer Res Treat; 2020 Nov; 184(2):615-626. PubMed ID: 33068197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Finch A; Poll A; Horsman D; Kim-Sing C; Scott J; Royer R; Sun P; Narod SA
    Br J Cancer; 2009 Jan; 100(2):421-5. PubMed ID: 19088722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic density and breast cancer risk by family history in women of white and Asian ancestry.
    Maskarinec G; Nakamura KL; Woolcott CG; Conroy SM; Byrne C; Nagata C; Ursin G; Vachon CM
    Cancer Causes Control; 2015 Apr; 26(4):621-6. PubMed ID: 25761408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium.
    Durham DD; Roberts MC; Khan CP; Abraham LA; Smith RA; Kerlikowske K; Miglioretti DL
    Cancer Causes Control; 2021 Jan; 32(1):103-107. PubMed ID: 33098534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
    Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
    Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
    J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk after childbirth in young women with family history (Denmark).
    Wohlfahrt J; Olsen JH; Melby M
    Cancer Causes Control; 2002 Mar; 13(2):169-74. PubMed ID: 11936823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.
    Kurian AW; Gong GD; John EM; Johnston DA; Felberg A; West DW; Miron A; Andrulis IL; Hopper JL; Knight JA; Ozcelik H; Dite GS; Apicella C; Southey MC; Whittemore AS
    J Clin Oncol; 2011 Dec; 29(34):4505-9. PubMed ID: 22042950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in relatives of
    Liu J; Yao L; Sun J; Hu L; Chen J; Zhang J; Xu Y; Xie Y
    Cancer Biol Med; 2023 Mar; 20(2):147-54. PubMed ID: 36861435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
    Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
    J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
    Reiner AS; John EM; Brooks JD; Lynch CF; Bernstein L; Mellemkjær L; Malone KE; Knight JA; Capanu M; Teraoka SN; Concannon P; Liang X; Figueiredo JC; Smith SA; Stovall M; Pike MC; Haile RW; Thomas DC; Begg CB; Bernstein JL
    J Clin Oncol; 2013 Feb; 31(4):433-9. PubMed ID: 23269995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history and prostate cancer risk in a population-based cohort of Iowa men.
    Cerhan JR; Parker AS; Putnam SD; Chiu BC; Lynch CF; Cohen MB; Torner JC; Cantor KP
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):53-60. PubMed ID: 9950240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.
    Antwi SO; Fagan SE; Chaffee KG; Bamlet WR; Hu C; Polley EC; Hart SN; Shimelis H; Lilyquist J; Gnanaolivu RD; McWilliams RR; Oberg AL; Couch FJ; Petersen GM
    J Natl Cancer Inst; 2019 Mar; 111(3):264-271. PubMed ID: 29982661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
    Moran A; O'Hara C; Khan S; Shack L; Woodward E; Maher ER; Lalloo F; Evans DG
    Fam Cancer; 2012 Jun; 11(2):235-42. PubMed ID: 22187320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.
    Claus EB; Schildkraut J; Iversen ES; Berry D; Parmigiani G
    J Natl Cancer Inst; 1998 Dec; 90(23):1824-9. PubMed ID: 9839523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
    Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
    Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.